Risk-reducing early salpingectomy and delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary

BJOG. 2019 Jun;126(7):831-839. doi: 10.1111/1471-0528.15651. Epub 2019 Mar 14.

Authors

F Gaba^{1

2}, J Piek³, U Menon⁴, R Manchanda^{1

2

4}

Affiliations

¹ Barts Cancer Institute, Queen Mary University of London, London, UK.
² Department of Gynaecological Oncology, St Bartholomew's Hospital, London, UK.
³ Department of Gynaecological Oncology, Catharina Hospital, Eindhoven, the Netherlands.
⁴ MRC Clinical Trials Unit, University College London, London, UK.

PMID: 30735593
DOI: 10.1111/1471-0528.15651

No abstract available

Publication types

Review

MeSH terms

Female
Genes, BRCA1
Genes, BRCA2
Heterozygote
Humans
Ovarian Neoplasms / genetics
Ovarian Neoplasms / prevention & control*
Ovariectomy / methods*
Premenopause
Primary Prevention / methods
Randomized Controlled Trials as Topic
Risk Reduction Behavior
Salpingectomy / methods*
Time-to-Treatment
Treatment Outcome

Associated data

GENBANK/NCT02321228
GENBANK/NCT01608074
GENBANK/NCT01907789
GENBANK/NCT02760849